350 rub
Journal Technologies of Living Systems №10 for 2012 г.
Article in number:
Aspects of pathogenesis of diabetic retinopathy in patients with diabetes of the second type
Authors:
I.V. Vorobievа
Abstract:
The main risk of diabetes - it-s specific complications. Diabetes mellitus belongs to polysystem diseases and leads to disruption of almost all organs and systems, and in the first place, the vision. Ophthalmic symptoms related to microvascular complications of diabetes. Ophthalmic symptoms of diabetes are microvascular complications of this disease. Diabetic retinopathy (DR) ? highly specific vascular lesions of the retina, it is equally characteristic of both insulin and for insulin dependent diabetes. Subclinical stage is a reversible stage of DR, so early diagnosis is important for the timely initiation of treatment. In recent decades, a significant increase in diagnostic capabilities in ophthalmology, which is associated with the appearance of new high-tech method of investigation of optical coherence tomography (OCT). The resolving power OCT is 10 times the permission other diagnostic methods, and involves the examination of the object at the level of microscopic tissue architecture. OCT provides an opportunity to see the layers of the retina in the form of 3D-image (the video format AVI) using OCT, we can clearly follow the dynamics of the process in the mode of progression, where the scanner automatically displays the map in the eyes of the first and next visits. According to the OCT can identify which retinal layers are more involved in the pathological process. Information about tissue received by using of OCT is the lifetime that is reflects not only the structure but also the characteristics of the functional state of tissues. OCT is non-invasive method. The method of OCT eliminates the injury and doesn-t have the limitations of conventional biopsy is well tolerated. It is also possible to observe the relative change in the dynamics of retinal layers on the background of laser photocoagulation and conservative therapy, evaluating the effectiveness of treatment. OCT provides speed and accuracy of research without the patient's central fixation eyes, comfort for the physician and patient. Perimetry to determine the qualitative change in the field of view that its values are superior to the physiological and pathological symptoms. Testing is the presentation of visual stimuli (object) in different areas of the field of view of the light level above the expected normal thresholds (above-threshold). The physical principle of OCT is analogous to ultrasound, with the only difference being that the OCT is used to probe biological tissue optical radiation in the near infrared (IR) wavelength range, not acoustic waves. The essence of the OCT is to measure the time delay of the light beam reflected from the tissue. The first lifetime scans passing through the fovea and optic disc were obtained in 1995, method is based on light interferonometriya. Kallikreins are localized in the plasma (plasma kallikrein) and tissues of some organs, particularly the pancreas and salivary glands and their secretions, the wall of the intestine, kidney and urinary, reproductive and sweat glands (tissue kallikreins). NO inhibits the work of the contractile apparatus of vascular smooth muscle elements, while activating the enzyme guanylate cyclase, and forms a secondary (or rather, the «tertiary») mediator - cyclic 3'-5'-guanosine monophosphate. It is believed that the vasodilatory (relaxation) effect of NO on the small blood vessels (arterioles, capillaries) directed against vasoconstrictor effect of endothelin-1 (aminopeptid).
Pages: 61-65
References
  1. Бородай А.В. Танакан в комплексном лечении  диабетической  ретинопатии: Дисс. на соиск. уч. ст. канд. мед. наук. М.: 2000.
  2. Дедов И.И., Шестакова М.В. Сахарный диабет - глобальная медико-социальная проблема современности // Consilium Medicum. 2009. Т. 11. № 12. С. 5-8.
  3. Демидова Т.Ю.Многофакторное управление метаболическими и сосудистыми нарушениями при сахарном диабете 2-го типа в сочетании с ожирением и артериальной гипертензией:Дисс. на соиск. уч. ст. докт. мед. наук. М. 2005.
  4. Либман Е.С., Скоробогатова Е.С. Эпидемиологические аспекты инвалидности вследствие офтальмодиабета // Ерошевские чтения / Тезисы докл. Всеросс. научно-практ. конф., посвященной 95-летию Т.И. Брошевского. Самара. 1997. С. 172-174
  5. Мошетова Л.К., Аржиматова Г.Ш., Строков И.А., Яровая Г.А. Современная антиоксидантная терапия диабетической ретинопатии // Клиническая офтальмология. 2006. Т. 7. № 1. С. 36 - 38.
  6. Мошетова Л.К., Бенделик Е.К., Алексеев И.Б.
    и др.
    Роль калликреин-кининовой системы в патогенезе контузии глаза // Вестник офтальмологии. 1999. Т. 115. № 1. С. 18-22
  7. Пасхина Т.С. Калликреин плазмы крови - новые функции // Биохимия. 1976. В. 6. С. 1347-1351
  8. Яровая Г.А. Калликреин-кининовая система: новые факты и концепции (обзор) // Вопросы
    медицинской химии. 2001. № 1. С. 20 - 38.
  9. Duncan A.M., Kladias A., Jennings G.L. et al. Kinins in humans // Am. J. Physiol Regul. Integr. Comp. Physiol. 2000. V. 278. № 4. P. 897-904.
  10. Griesbacher T. Kallikrein-kinin system in acute pancreatitis: potential role of B(2)- bradykinin antagonists and kallikrein inhibitors // Pharmacology. 2000. V. 60. № 3. Р. 113-120.
  11. Joanna A. Phipps, Allen C. Clermont, Sukanto Sinha, Tamie J. Chilcote,Sven-Erik Bursell, Edward P. Feener. Plasma Kallikrein Mediates Angiotensin II Type 1Receptor-Stimulated Retinal Vascular Permeability // Hypertension. 2009. V. 53. P. 175-181
  12. Kohner E.M., Stratton I.M., Aldington S.J. et al.Six year progression of diabetic retinopathy in the UK Prospective Diabetes Study // Diabetic Med. 1996. V. 13. P. 14.
  13. Margolius H.S. Kallikreins, kinins and cardiovascular diseases: a short review // Biol. Res. 1998. V. 31. № 3. P. 135-141
  14. Rojkar R., Schmaier A.H // Proc. Assoc. Am. Phys. 1999. V. 111. P. 220-227.
  15. Rothshild A.M., Melo V.L., Reis M.L. et al. Kininogen and prekallikrein increases in the blood of streptozocin-diabetic rats are normalized by insulin in vivo and in vitro // Naunyn-Schmiederberg - s Arch. Phsrmscol. 1999. V. 360. P. 217-220
  16. Wong P., Terragno A.D. Dual effects of bradykinin on prostaglandin metabolism: relationship to the dissimilar vascular action of kinins // Prostaglandins. 1977. V. 6. P. 113-1125.